|
Generic Name : Rotavirus Vaccine
Pronunciation : ROE-ta-vye-rus VAX-een, lyve
Therapeutic Classification : Immunizing Agents
ICD Code : Y59.0
♦ Safety Labeling Changes Approved By FDA
Trade Name(s): International- Rotarix, RotaTeq. Why it is prescribed (Indications) : This medication is a vaccine, prescribed for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types in infants and children. It helps the immune system to protect against rotavirus. When it is not to be taken (Contraindications): Contraindicated in patients with uncorrected congenital malformation of the gastrointestinal tract.
Dosage & When it is to be taken : The vaccination series consists of two 1-mL doses administered orally. The first dose should be administered to infants beginning at 6 weeks of age. There should be an interval of at least 4 weeks between the first and second dose. The 2-dose series should be completed by 24 weeks of age. How it should be taken : It comes as a solution to take by mouth. Warnings and Precautions : * Caution should be exercised in patients with history of gastrointestinal disorders, poor immunity and any allergy. * The healthcare provider should inform the parents or guardians about the possible adverse reactions. Side Effects : Most Common- Fussiness, irritability, cough, runny nose, fever, vomiting and diarrhea. Serious- Death and intestinal blockage. Blood and Lymphatic- Decrease in platelets and bruising. ♦ Gastrointestinal- Blood in the stools and intussusception. General- Maladministration. *Avoid excess dosage. Storage Conditions : Vial- Store it in refrigerator (2° to 8°C). Diluent- The diluent may be stored at a controlled room temperature 20° to 25°C. Do not freeze. Discard if the diluent has been frozen. |
![]() Comment & Contribute
![]()
![]() ![]() | ||



Ask an Expert